277 related articles for article (PubMed ID: 16084072)
1. [Use of human recombinant erythropoietin in children with cancer].
Guyot D; Margueritte G
Arch Pediatr; 2005 Sep; 12(9):1376-82. PubMed ID: 16084072
[TBL] [Abstract][Full Text] [Related]
2. The role of recombinant human erythropoietin in the management of anaemic cancer patients: focus on haematological malignancies.
Osterbor A
Med Oncol; 2000 Nov; 17 Suppl 1():S17-22. PubMed ID: 11188781
[TBL] [Abstract][Full Text] [Related]
3. The role of recombinant erythropoietin in childhood cancer.
Shankar AG
Oncologist; 2008 Feb; 13(2):157-66. PubMed ID: 18305061
[TBL] [Abstract][Full Text] [Related]
4. [Human recombinant erythropoietin therapy].
Donato H; Ferro H
Medicina (B Aires); 2006; 66(1):51-69. PubMed ID: 16555732
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment.
Baron F; Frère P; Fillet G; Beguin Y
Clin Cancer Res; 2003 Nov; 9(15):5566-72. PubMed ID: 14654537
[TBL] [Abstract][Full Text] [Related]
6. [Clinical use of erythropoietin].
Franchini M; Gandini G; Lippi G; De Gironcoli M; Cantini M; Aprili G
Recenti Prog Med; 2004 Mar; 95(3):129-36; quiz 185. PubMed ID: 15143948
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of anaemia in patients with malignancy: implications for the clinical use of recombinant human erythropoietin.
Cazzola M
Med Oncol; 2000 Nov; 17 Suppl 1():S11-6. PubMed ID: 11188780
[TBL] [Abstract][Full Text] [Related]
8. The impact and management of anaemia in haematological malignancies.
Coiffier B
Med Oncol; 2000 Nov; 17 Suppl 1():S2-10. PubMed ID: 11188782
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human erythropoietin (rHuEPO) therapy in patients with cancer-related anaemia: what have we learned?
Osterborg A
Med Oncol; 1998 Aug; 15 Suppl 1():S47-9. PubMed ID: 9785337
[No Abstract] [Full Text] [Related]
10. Successful treatment of anemia in idiopathic myelofibrosis with recombinant human erythropoietin.
Hasselbalch HC; Clausen NT; Jensen BA
Am J Hematol; 2002 Jun; 70(2):92-9. PubMed ID: 12111781
[TBL] [Abstract][Full Text] [Related]
11. Cost-utility analysis of recombinant human erythropoietin in anemic cancer patients induced by chemotherapy in Thailand.
Roungrong J; Teerawattananon Y; Chaikledkaew U
J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S119-25. PubMed ID: 19255987
[TBL] [Abstract][Full Text] [Related]
12. Anemia of cancer: pathogenesis and treatment with recombinant erythropoietin.
Mittelman M
Isr J Med Sci; 1996 Dec; 32(12):1201-6. PubMed ID: 9007154
[TBL] [Abstract][Full Text] [Related]
13. Anemia in multiple myeloma.
Ludwig H; Pohl G; Osterborg A
Clin Adv Hematol Oncol; 2004 Apr; 2(4):233-41. PubMed ID: 16163188
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.
Corapcioglu F; Aksu G; Basar EZ; Demirel A; Oncel S; Mutlu A
Pediatr Hematol Oncol; 2008 Sep; 25(6):509-21. PubMed ID: 18728970
[TBL] [Abstract][Full Text] [Related]
15. Alfa-epoietin and anaemia in gynaecological cancer.
Di Cocco B; Salesi N; Fabi A; Nardoni C; Ferretti G; Bossone G; Ciccarese M; Savarese A; Vecchione A; Cognetti F
Anticancer Res; 2004; 24(2C):1287-92. PubMed ID: 15154662
[TBL] [Abstract][Full Text] [Related]
16. Is a prophylactic treatment by erythropoietin relevant to reduce red blood cell transfusion in the pediatric intensive care unit?
Liet JM; Paranon S; Baraton L; Dejode JM; Rozé JC
Pediatr Crit Care Med; 2006 Nov; 7(6):541-4. PubMed ID: 17006380
[TBL] [Abstract][Full Text] [Related]
17. [Severe, life-threatening renal anemia treatment in patients who do not accept heterologous blood transfusion for religious reasons--case report].
Jaroszyński AJ; Bober-Palak E; Jóźwiak L; Ksiazek A
Przegl Lek; 2007; 64(7-8):528-30. PubMed ID: 18409359
[TBL] [Abstract][Full Text] [Related]
18. [Indications and limits of recombinant human erythropoietin in intensive care unit].
Ventré C; Rousseau S; Albanèse J; Leone M; Martin C
Ann Fr Anesth Reanim; 2004 Jul; 23(7):714-21. PubMed ID: 15324960
[TBL] [Abstract][Full Text] [Related]
19. Nandrolone decanoate for the treatment of erythropoietin refractory anemia: a case series.
Chawla B; Iqbal FM; Chawla MS
Compr Ther; 2009; 35(3-4):199-203. PubMed ID: 20043618
[TBL] [Abstract][Full Text] [Related]
20. EPO's alter ego: erythropoietin has multiple actions.
Lappin TR; Maxwell AP; Johnston PG
Stem Cells; 2002; 20(6):485-92. PubMed ID: 12456956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
